Matthieu Schäfer

Matthieu Schäfer

Auto-generated profile, based on publicly available information

Matthieu Schäfer

University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine, Cologne, Germany.

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2025 in JACC: Cardiovascular Interventions
Verified
Journal Article
Open access
CHCaroline Hasse
Caroline Hasse
PSPhilipp von Stein
Philipp von Stein
JAJan Althoff
Jan Althoff
JCJonathan Curio
Jonathan Curio
MSMatthieu Schäfer
Matthieu Schäfer
MKMaria I. Koerber
Maria I. Koerber
Transcatheter tricuspid valve annuloplasty (TTVA) with the Cardioband has proved to be safe and effective in acutely reducing tricuspid regurgitation (TR). However, long-term outcomes, especially regarding right heart remodeling (RHR), are scarce. The aim of this study was to assess long-term efficacy as well as RHR following TTVA. This retrospective, multicenter study included consecutive patients undergoing TTVA for severe TR at 2 German high-volume centers from 2019 to 2023. Right atrial and right ventricular (RV) parameters and NYHA functional class were assessed at baseline and follow-up. A total of 156 patients were included, and the median time to follow-up was 435 days (Q1-Q3: 156-704 days). TR reduction to ≤2+ was observed in 71% and NYHA functional class improved to ≤II in 68% (P < 0.001 for both). Compared with baseline, right atrial area (36.0 ± 10.1 cm2 vs 30.4 ± 10.7 cm2), RV length (67.5 ± 9.4 mm vs 63.7 ± 9.1 mm), RV midventricular dimension (42.6 ± 8.6 mm vs 35.6 ± 7.8 mm), and RV basal dimension (47.8 ± 6.8 mm vs 42.6 ± 7.5 mm)were significantly reduced at follow-up (P < 0.001 for all). Notably, torrential to severe TR reduction still yielded remodeling (RV basal diameter 50 ± 8.1 mm vs 44 ± 8 mm; P = 0.007). RHR was associated with a decrease in vena contracta width (OR: 1.14; 95% CI: 1.03-1.30; P = 0.015). TTVA is associated with a significant and sustained reduction of TR for more than 1 year. Additionally, patients demonstrated distinct positive cardiac remodeling and functional improvement.

15 February 2024 in Clinical Research in Cardiology
Verified
Journal Article
Open access
PDF file
MSMatthieu Schäfer
Matthieu Schäfer
HNHannah Nöth
Hannah Nöth
CMClemens Metze
Clemens Metze
CIChristos Iliadis
Christos Iliadis
MKMaria Isabel Körber
Maria Isabel Körber
RPRoman Pfister
Roman Pfister
Background: Frailty is common in elderly and multimorbid patients and associated with increased vulnerability to stressors. Methods: In a single centre study frailty according to Fried criteria was assessed in consecutive patients before transcatheter mitral and tricuspid valve repair. Postprocedural infections, blood transfusion and bleeding and renal failure were retrospectively assessed from records. Median follow-up time for survival was 560 days (IQR: 363 to 730 days). Results: 90% of 626 patients underwent mitral valve repair, 5% tricuspid valve repair, and 5% simultaneous mitral and tricuspid valve repair. 47% were classified as frail. Frailty was associated with a significantly increased frequency of bleeding (16 vs 10%; p = 0.016), blood transfusions (9 vs 3%; p = < 0.001) and infections (18 vs 10%; p = 0.006), but not with acute kidney injury (20 vs 20%; p = 1.00). Bleeding and infections were associated with longer hospital stays, with a more pronounced effect in frail patients (interaction test p < 0.05, additional 3.2 and 4.1 days in frail patients, respectively). Adjustment for the occurrence of complications did not attenuate the increased risk of mortality associated with frailty (HR 2.24 [95% CI 1.62–3.10]; p < 0.001). Conclusions: Bleeding complications and infections were more frequent in frail patients undergoing transcatheter mitral and tricuspid valve repair and partly explained the longer hospital stay. Albeit some of the complications were associated with higher long-term mortality, this did not explain the strong association between frailty and mortality. Further research is warranted to explore interventions targeting periprocedural complications to improve outcomes in this vulnerable population. Graphical

17 February 2026 in Clinical Research in Cardiology
Verified
Journal Article
Open access
MSMatthieu Schäfer
Matthieu Schäfer
CMClemens Metze
Clemens Metze
CHCaroline F. Hasse
Caroline F. Hasse
JAJan Althoff
Jan Althoff
TGThorsten Gietzen
Thorsten Gietzen
RPRoman Pfister
Roman Pfister
Background: Current guidelines recommend frailty assessment for risk stratification of candidates for transcatheter mitral and tricuspid valve repair (TMTVR), but it remains unclear which frailty score is most appropriate. Methods: In a retrospective monocentric analysis of patients who received TMTVR, a modified version of the essential frailty toolset (EFT) was calculated from four categories: gait speed, cognitive impairment, hemoglobin, and serum albumin. Cox proportional hazards models were used to examine the association between EFT frailty and all-cause mortality. Results: A total of 206 patients were analyzed; median age was 76 [72–82] years, and 55% were male. According to the EFT, 49 patients (24%) were non-frail, 127 patients (62%) were pre-frail, and 30 patients (15%) were frail. Estimated survival at 2 years was 88 ± 5% for non-frail patients, 74 ± 5% for pre-frail patients, and 62 ± 10% for frail patients, with a hazard ratio of 1.54 (95% CI 1.16–2.04; p = 0.003) per standard deviation of EFT score. This association remained virtually unchanged when adjusted for other risk factors and Fried physical frailty, but disappeared when adjusted for the multidimensional prognostic index (MPI), which is based on a comprehensive geriatric assessment. A stepwise approach using EFT in all patients and MPI only in pre-frail EFT patients resulted in two risk categories with a 4.4-fold (95% CI 2.3–9.4) difference in 2-year mortality between categories. Conclusions: The EFT has prognostic value for patients undergoing TMTVR. Due to its simplicity, the EFT could serve as a first-line frailty assessment tool to guide therapeutic decision-making, potentially in a stepwise approach with MPI. Graphical Modified Essential Frailty Toolset (EFT) (adapted from J. Afilalo et al., JACC [2017]) [14] and Kaplan–Meier survival plots for all-cause mortality by frailty according to the EFT score